Leptin System in Obese Dog Skin: A Pilot Study
Margherita Maranesi1, Antonio Di Loria2, Cecilia Dall'Aglio1
1Department of Veterinary Medicine, University of Perugia, via San Costanzo 4, 06126 Perugia, Italy.
Animals : an Open Access Journal From MDPI
|December 15, 2020
Summary
Obese dogs show altered leptin receptor (LEPR) gene expression in their skin, suggesting a role in obesity-related skin changes. Further research is needed to understand leptin
Area of Science:
- Veterinary Dermatology
- Obesity Research
- Animal Physiology
Background:
- Obesity is linked to various health issues, including skin diseases, but its impact on pet skin is poorly understood.
- Leptin (LEP), a hormone primarily from adipose tissue, plays a significant role in skin biology.
- Limited data exists on the leptin system's function in the skin of obese animals.
Purpose of the Study:
- To investigate the leptin (LEP) system within the skin of obese dogs compared to normal-weight dogs.
- To evaluate potential differences in skin-associated immune cells between the groups.
Main Methods:
- Comparative study involving 10 obese and 10 normal-weight dogs.
- Analysis of skin samples using Real-time PCR for gene expression (LEP and LEPR).
- Immunohistochemistry to visualize LEP and LEPR protein distribution.
- Evaluation of skin-associated immune system cell composition.
Main Results:
- No significant differences in skin inflammation or LEP gene expression were found between obese and normal-weight dogs.
- A notable 10-fold increase in leptin receptor (LEPR) transcript levels was observed in the skin of obese dogs.
- LEP and LEPR proteins were detected in various skin structures, including epidermis, hair follicles, and glands, with no group differences in immune cell composition.
Conclusions:
- This preliminary study indicates alterations in the leptin system within the skin of obese dogs.
- The significantly increased LEPR expression in obese dogs suggests a potential modulating role for the receptor in systemic control.
- The precise function of leptin in canine skin under obese conditions requires further comprehensive investigation.
More Related Videos
Related Concept Videos
Drug Dosing: Obese Patients
90
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
90
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
81
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
81
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
112
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
112
Obesity
938
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
938


